**Anti-VEGF (Vascular Endothelial Growth Factor) Injections** are the most revolutionary and common treatment for several sight-threatening retinal diseases. They work by blocking a protein called VEGF, which is responsible for stimulating the growth of abnormal, leaky blood vessels and causing fluid buildup in the macula.
We utilize leading Anti-VEGF medications, including **Lucentis**, **Eylea**, and off-label **Avastin**, delivered directly into the vitreous (intravitreal injection) to stop leakage, reduce macular swelling, and prevent further vision loss in conditions like **Wet Age-related Macular Degeneration (AMD)**, **Diabetic Macular Edema (DME)**, and **Retinal Vein Occlusion (RVO)**.
Stops the growth of abnormal blood vessels that cause rapid central vision loss in Age-related Macular Degeneration.
Reduces macular swelling and leakage caused by uncontrolled diabetes, preserving reading vision.
Performed under strict sterile conditions with topical anesthesia, making the procedure quick and comfortable.
Effective treatment for Macular Edema following Retinal Vein Occlusions (RVO).